Adenomyosis, a common benign disease of women of childbearing age, is caused by the presence of heterotopic endometrial glands and stroma within the myometrium (1,2). The primary clinical manifestations of adenomyosis are prolonged menstruation, menorrhagia and secondary ingra- vescence dysmenorrhea
LI CAIXIA,RONG CHEN,CAIXIA JIANG,LI CHEN,ZHONGPING CHENG
2018-01-01
Abstract:Adenomyosis is a common benign disease of women of childbearing age. The typical clinical features are prolonged menstruation, menorrhagia and ingravescent dysmenorrhea. In the present study, the severity of dysmenorrhea was assessed using the visual analogue scale system as follows: 0, No pain; 1-3, minimal pain; 4-6, moderate pain; and 7-10, severe pain. Menstrual blood loss was evaluated using the pictorial blood loss assessment chart (PBAC). Menorrhagia was defined as excessive menstrual blood loss >80 ml (PBAC >100) per period. Specimens of eutopic endometrium (EU) and ectopic endometrium (EC) were collected from 20 patients with adenomyosis to evaluate the association between lipoxygenase-5 (LOX-5) and cyclooxygenase 2 (COX‐2) and inflammatory pathology and clinical features of adenomyosis. For that purpose, the expression levels of LOX-5, COX-2, interleukin (IL)-6 and IL-8 in the EU and EC of patients with adenomyosis were determined, and clinical data including dysmenorrhea and menstruation were analyzed. Differences in expression levels of LOX-5 and COX-2 were detected, and the correlations between LOX-5, COX-2, IL-6 and IL-8 in different groups were analyzed. In addition, the correlations between LOX-5, COX-2 and clinical features of adenomyosis were investigated. The present study demonstrated that LOX-5 and COX-2 are overexpressed in EU and EC, and they have positive correlations with IL-6 and IL-8, suggesting that adenomyosis lesions are present in inflammatory pathological conditions. The expression levels of LOX-5 and COX-2 exhibited a correlation with dysmenorrhea and menstruation. Introduction Adenomyosis, a common benign disease of women of childbearing age, is caused by the presence of heterotopic endometrial glands and stroma within the myometrium (1,2). The primary clinical manifestations of adenomyosis are prolonged menstruation, menorrhagia and secondary ingravescence dysmenorrhea. It is common to observe increased uterine volume in adenomyosis. A number of patients have high levels of serum CA125. CA125 modified by platelet count and neutrophil-lymphocyte ratio improves the predictive accuracy of adenomyosis-derived pelvic dense adhesion (3). Adenomyosis was considered to be a chronic immune inflammatory disease. Lesions, peripheral blood and/or peritoneal fluid in patients with adenomyosis are rich in a variety of inflammatory immune cells and inflammatory cytokines, and are closely associated with its clinicopathological features (4-7). Guo et al (8) observed that the expression of Toll-like receptor 4 (TLR4) in adenomyosis was increased compared with the normal endometrium. An established cell model revealed that bacterial lipopolysaccharide can promote the inflammatory response and cell proliferation of endometrial stromal cells in adenomyosis, and improved the ability of invasion via the TLR4 signaling pathway. Cyclooxygenase 2 (COX-2) is a key enzyme in the process of synthesis of various endogenous prostaglandins with arachidonic acid. It was called ‘stress gene’ and can be detected only when its expression is stimulated by inflammatory factors, but not in normal tissue. COX‐2 has certain associations with inflammation, cell mitosis and specific signaling transduction pathways. COX-2 regulates the occurrence and development of a wide variety of tumor pathophysiological processes alongside its inflammatory metabolites (9). A previous study demonstrated that targeting the COX‐2 gene can significantly inhibit the expression of vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 in eutopic and ectopic endometrial stromal cells, as well as increase the rate of apoptosis (10,11). Lipoxygenase-5 (LOX-5) is the key enzyme catalyzing the reaction of arachidonic acid to generate leukotrienes. It is present only in a few cell types (including granulocytes, mast cells, dendritic cells and B lymphocytes), and its metabolic products are important inflammatory mediators. A Correlation of LOX‐5 and COX‐2 expression with inflammatory pathology and clinical features of adenomyosis CAIXIA LI1*, RONG CHEN1*, CAIXIA JIANG2, LI CHEN3 and ZHONGPING CHENG1,4 1Department of Gynecology and Obstetrics, Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072; 2Department of Gynecology and Obstetrics, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200090; 3Department of Oncology, Shanghai Pudong Hospital, Fudan University, Shanghai 201399; 4Department of Gynecological Minimally Invasive Surgery Research Center, Tongji University School of Medicine, Shanghai 200072, P.R. China Received April 21, 2018; Accepted September 20, 2018 DOI: 10.3892/mmr.2018.9618 Correspondence to: Dr Zhongping Cheng, Department of Gynecology and Obstetrics, Tenth People's Hospital, Tongji University School of Medicine, 301 Yan Chang Road, Shanghai 200072,